期刊文献+

血脂和甲状腺激素水平测定在冠心病心力衰竭严重程度诊断中的临床研究 被引量:2

Clinical Study of Severity Diagnosis through Determining Blood Lipid and TH Levels in Patients with Heart Failure of CHD
下载PDF
导出
摘要 目的探讨血脂和甲状腺激素水平测定在冠心病(CHD)心力衰竭严重程度诊断中的临床应用.方法采用生化法和化学发光免疫分析测定136例CHD心力衰竭患者和36例急性心肌梗死(AMI)患者的血脂和血清甲状腺激素(TH)水平并与60名正常对照组进行比较分析.结果 CHD心力衰竭患者血清TC、TG和LDL-C水平较之正常对照组明显增高(P均〈0.05),并随心力衰竭的严重程度而降低,血清HDL-C水平稍降低与正常对照组无明显差异(P〉0.05),也随心力衰竭的严重程度而降低,AMI患者血脂指标均降低(P均〈0.05).在TH分析中,CHD心力衰竭患者血清T3和FT3的水平较之正常对照组明显降低(P均〈0.05),并随心力衰竭的严重程度而降低, AMI患者血清T3和FT3水平为最低,CHD心力衰竭和AMI患者的血清T4、FT4和TSH水平较之正常对照组无明显差异(P均〉0.05).结论 CHD心力衰竭患者血脂代谢紊乱,血清TC、TG和LDL-C明显增高,而T3和FT3明显降低,血脂和TH水平均随CHD心力衰竭的严重程度而降低. Objective To explore the clinical application of severity diagnosis through determining blood lipid and TH levels in patients with heart failure of CHD.Methods Blood lipid(TC,TG,HDL-C and LDL-C)(with biochemistry method) and serum TH(T3,T4,FT3,FT4 and TSH)(with chemiluminescence immunoassay) levels were determined in 136 patients with heart failure of CHD(including classⅠ38 cases,class Ⅱ 33 cases,class Ⅲ 34 cases and class Ⅳ 31 cases),36 patients with AMI and 60 normal controls.Results Serum TC,TG and LDL-C levels in patients with heart failure of CHD were significantly higher than those in controls(P all〈0.05),and decreased with severity of heart failure,but serum HDL-C level was not significantly different from those in controls,and decreased with severity of heart failure also.The four indexes of blood lipid in patient with AMI were lowest in these patients(P all〈0.05).In TH analysis,serum T3 and FT3 levels in patients with heart failure of CHD were significantly lower than those in controls(P all〈0.05),and decreased with severity of heart failure.Serum T3 and FT3 levels in patients with AMI were lowest.Serum T4,FT4 and TSH levels in patients with heart failure of CHD and in patients with AMI were not significantly different from those in controls(P all〉0.05).Conclusion There was abnormal metabolism in patients with heart failure of CHD.Serum TC,TG and LDL-C levels significantly increased,but serum T3 and FT3 levels significantly deceased,and they decreased with severity of heart failure.
作者 孙翠平
出处 《中国血液流变学杂志》 CAS 2013年第1期149-151,153,共4页 Chinese Journal of Hemorheology
关键词 冠心病(CHD) 心力衰竭 血脂 甲状腺激素(TH) 严重程度 coronary heart disease(CHD) heart failure blood lipid thyoid hormone(TH) severity
  • 相关文献

参考文献8

  • 1周新,鄢盛恺.临床血脂分析的现状与发展[J].中华检验医学杂志,2003,26(7):393-395. 被引量:49
  • 2Ito T, Shiomi M.Cerebral atherosclerosis occurs spontan- eously in homozygous WHHL rabbits[J].Atherosclerosis,2001,156(1):57 - 66.
  • 3Bonville DA,Parker TS,Levine DM,et al.The relationships of hypocholesterolemia to cytokine concentrations and mortality in critically ill patients with systemic inflammatory response syndrome[J].Surg Infect(Larchmt), 2004,5(1):39 - 49.
  • 4Charrin S,Manie S,Thiele C,et al.A physical and functional link between cholesterol and tetraspanins[J].Eur J Immunol,2003,33(9):2479 - 2489.
  • 5Chien JY, Jerng JS,Yu CJ,et al.Low serum level of high- density lipoprotein cholesterol is a poor prognostic factor for severe sepsis[J].Crit Care Med,2005,33(8): 1688 - 1693.
  • 6Abadie JM,Malcom GT, Porter JR,et al.Dehydroepiand- rosterone alters Zucker rat soleus and cardiac muscle lipid profiles[J].Exp Biol Med(Maywood),2001,226(8): 782 - 789.
  • 7刘晓柳,李光千.心血管系统雄激素受体及雄激素保护作用的研究进展[J].国际检验医学杂志,2006,27(1):71-73. 被引量:4
  • 8吴卫元,杨永青.甲状腺激素在心血管疾病诊断和治疗中的临床应用[J].国际放射医学核医学杂志,2010,34(4):223-225. 被引量:6

二级参考文献29

  • 1杜馥曼,刘彤梅,王嵬民.血清甲状腺素水平与心力衰竭关系分析[J].放射免疫学杂志,2006,19(3):205-206. 被引量:2
  • 2Leowattana W.DHEA(S):the fountain of youth.J Med Assoc Thai,2001,84(Suppl 2):S605-S612.
  • 3Jenster G,Spencer TE,Burcin MM,et al.Steroid receptor induction of gene transcription:a two-step model.Proc Natl Acad Sci USA,1997,94(15):7879-7884.
  • 4Pawlowski JE,Ertel JR,Allen MP,et al.Liganded androgen receptor interaction with beta-catenin:nuclear co-localization and modulation of transcriptional activity in neuronal cells.J Biol Chem,2002,277(23):20702-20710.
  • 5Jorgensen JS,Nilson JH.AR suppresses transcription of the alpha glycoprotein hormone subunit gene through protein-protein interactions with cJun and activation transcription factor 2.Mol Endocri nol,2001,15(9):1496-1504.
  • 6Kousteni S,Bellido T,Plotkin LI,et al.Nongenotropic,sex-nonspecific signaling through the estrogen or androgen receptors:dissociation from transcriptional activity.Cell,2001,104 (5):719-730.
  • 7Peterziel H,Mink S,Schonert A,et al.Rapid signalling by androgen receptor in prostate cancer cells.Oncogene,1999,18 (46):6322-6329.
  • 8Lieberherr M,Grosse B.Androgens increase intracellular calcium concentration and inositol 1,4,5 trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G protein.J Biol Chem,1994,269(10):7217-7223.
  • 9Marsh JD,Lehmann MH,Ritchie RH,et al.Androgen receptors mediate hypertrophy in cardiac myocytes.Circulation,1998,98(3):256-261.
  • 10Abadie JM,Malcom GT,Porter JR,et al.Dehydroepiandrosterone alters Zucker rat soleus and cardiac muscle lipid profiles.Exp Biol Med (Maywood),2001,226(8):782-789.

共引文献56

同被引文献14

  • 1陈柏香,尤艳青,陈美珠.颅脑损伤患者血清甲状腺激素水平的变化及临床意义[J].放射免疫学杂志,2006,19(1):42-43. 被引量:2
  • 2Oncel C, Demir S, Gtiler S, et al. Association between cholesterols, homocysteine and silent brain infarcts[J]. In- tern Med J, 2009, 39(3):150-155.
  • 3European Association for Cardiovascular Prevention & Re- habilitation, Reiner Z, Catapano AL, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology(ESC) and the European Atherosclero- sis Society (EAS)[J]. Eur Heart J, 2011, 32(14):1769-1818.
  • 4Hassing HC, Surendran RP, Mooij HL, et al. Pathophysiol- ogy of hypertriglyceridemia[J]. Biochim Biophys Acta, 2012, 1821(5):826-832.
  • 5Momjian-Mayor I, Baron JC. The pathophysiology of water- shed infraction in internal carotid artery disease: review of cerebral perfusion studies[J]. Stroke, 2005, 36(3):567-577.
  • 6Saposnik G, Ray JG, Sheridan P, et al. Homocysteine-low- ering therapy and stroke risk, severity, and disability: addi- tional findings from the HOPE 2 tral[J]. Stroke, 2009, 40(4): 1365-1372.
  • 7Roudbary SA, Saadat F, Forghanparast K, et al. Serum C- reactive protein level as a biomarker for differentiation of ischemic from hemorrhagic stroke[J]. Acta Med Iran, 2011, 49(3):149-152.
  • 8Oh HG, Rhee E J, Kim TW, et al. Higher glycated hemoglobin level is associated with increased risk for is-chemic troke in nondiabertic Korean male adults[J]. Dia- betes Metab J, 2011, 35(5):551-557.
  • 9Folsom AR, Pankow JS, Tracy RP, et al. Association of C-reactive protein with markers of prevalent atheroscle- rotic disease[J]. Am J Cardiol, 2001, 88(2): 112-117.
  • 10吴卫元,杨永青.甲状腺激素在心血管疾病诊断和治疗中的临床应用[J].国际放射医学核医学杂志,2010,34(4):223-225. 被引量:6

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部